Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesTissue DonorsWhole-Body IrradiationLeukemiaTransplantation, AutologousAnemia, AplasticKidney TransplantationGraft SurvivalCytomegalovirus InfectionsImmunosuppressive AgentsHematopoietic Stem Cell TransplantationGraft RejectionHematopoietic Stem CellsHistocompatibility TestingTransplantation ConditioningBone RemodelingImmunocompromised HostBone Marrow DiseasesHematologic NeoplasmsImmunosuppressionHistocompatibilityTime FactorsTransplantsBone Marrow ExaminationOpportunistic InfectionsCyclosporineBone Marrow PurgingBone Marrow NeoplasmsTreatment OutcomeLeukemia, Myeloid, AcuteTransplantation ChimeraRetrospective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoiesisPrecursor Cell Lymphoblastic Leukemia-LymphomaMice, Inbred C57BLMycosesRecurrenceCytomegalovirusBone DensityRadiation ChimeraFatal OutcomeBusulfanTransplantation, IsogeneicAcute DiseaseTransplantationHLA AntigensHeart TransplantationGanciclovirBone ResorptionHematologic DiseasesSurvival AnalysisPneumonia, ViralColony-Forming Units AssayNuclear FamilyCyclophosphamideLymphocyte DepletionAspergillosisPostoperative ComplicationsCombined Modality TherapyT-LymphocytesGraft vs Host ReactionMyelodysplastic SyndromesBlood Group IncompatibilityLeukemia, MyeloidCell DifferentiationAntilymphocyte SerumHepatic Veno-Occlusive DiseaseLung TransplantationCystitisFollow-Up StudiesPolymerase Chain ReactionLiving DonorsMucormycosisBone NeoplasmsSurvival RateBK VirusLymphoma, Non-HodgkinLymphocyte TransfusionFlow CytometryCells, CulturedInfectionLeukocyte CountHerpesvirus 6, HumanBone DevelopmentChimeraBone DiseasesAntigens, CD34SpleenRisk FactorsProspective StudiesMice, Inbred BALB CMultiple MyelomaDisease-Free SurvivalRemission Induction